Skip to main content

Table 1 Study design and subject allocation

From: Randomized, double-blind, placebo-controlled phase I dose escalation study of Dan Qi Tong Mai tablet in healthy volunteers

Cohort

Single-dose study (once)

Multiple-dose study (twice daily for 14 days)

1

2

3

4

5

6

7

8

9

10

11

Increase,%

Starting dose

200

100

100

67

60

50

33

–

–

–

Dosea

90

270

540

1080

1800

2880

4320

5760

360

720

2160

Men

3

4

4

4

4

4

4

3

4

4

4

Women

3

4

4

4

4

4

4

3

4

4

4

Group allocation

 Active ingredients

4

6

6

6

6

6

6

4

6

6

6

 Placebo

2

2

2

2

2

2

2

2

2

2

2

 Total

6

8

8

8

8

8

8

6

8

8

8

  1. amg of active ingredients